Pilot experience with opebacan/rBPI21 in myeloablative hematopoietic cell transplantation [version 1; referees: 2 approved]

Pilot experience with opebacan/rBPI21 in myeloablative hematopoietic cell transplantation [version 1; referees: 2 approved]

Bacterial infection and inflammation contribute significantly to the morbidity and mortality of myeloablative allogeneic hematopoietic cell transplantation (HCT). Endotoxin, a component of the outer membrane of Gram-negative bacteria, is a potent inflammatory stimulus in humans. Bactericidal/permeab...

Full description

Bibliographic Details
Main Authors:	Eva Guinan, David E Avigan, Robert J Soiffer, Nancy J Bunin, Lisa L Brennan, Ilana Bergelson, Spencer Brightman, Al Ozonoff, Patrick J Scannon, Ofer Levy
Format:	Article
Language:	English
Published:	F1000 Research Ltd 2015-12-01
Series:	F1000Research
Subjects:	Bacterial Infections
Online Access:	http://f1000research.com/articles/4-1480/v1

Similar Items

rBPI(21) promotes lipopolysaccharide aggregation and exerts its antimicrobial effects by (hemi)fusion of PG-containing membranes.
by: Marco M Domingues, et al.
Published: (2009-12-01)

RBPI: cinqüenta anos
by: Antônio Carlos Lessa
Published: (2007-12-01)

A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations
by: Erden Atilla, et al.
Published: (2017-02-01)

Prevalence of chimerism after non-myeloablative hematopoietic stem cell transplantation
by: Azulamara da Silva Ruiz, et al.

Thrombopoietin from hepatocytes promotes hematopoietic stem cell regeneration after myeloablation
by: Longfei Gao, et al.
Published: (2021-08-01)

O tratamento de temas multilaterais na RBPI: 1958-1998
by: Antonio Jorge Ramalho da Rocha
Published: (1998-01-01)

Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery
by: Michael M. B. Green, et al.
Published: (2016-08-01)

Myeloablative hematopoietic stem cell transplantation improves survival but is not curative in a pre-clinical model of myelodysplastic syndrome.
by: Yang Jo Chung, et al.
Published: (2017-01-01)

Patients Undergoing Myeloablative Chemotherapy and Hematopoietic Stem Cell Transplantation Exhibit Depleted Vitamin C Status in Association with Febrile Neutropenia
by: Anitra C. Carr, et al.
Published: (2020-06-01)

Cyclosporine A trough concentrations are associated with acute GvHD after non-myeloablative allogeneic hematopoietic cell transplantation.
by: Elizabeth A de Kort, et al.
Published: (2019-01-01)

International Security and Defense - Taking stock of Brazil’s changes: a special issue of RBPI
by: Eugenio Pacelli Lazzarotti Diniz Costa, et al.
Published: (2017-11-01)

Addition of venetoclax to myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in high-risk AML
by: Xing-yu Cao, et al.
Published: (2023-12-01)

Across the Myeloablative Spectrum: Hematopoietic Cell Transplant Conditioning Regimens for Pediatric Patients with Sickle Cell Disease
by: Emily Limerick, et al.
Published: (2022-07-01)

Improved engraftment and therapeutic efficacy by human genome-edited hematopoietic stem cells with Busulfan-based myeloablation
by: Edina Poletto, et al.
Published: (2022-06-01)

RBPI and the Study of IR: Fostering a Multifaceted Platform for Global Dialogue, Debate and Academic Cooperation
by: Haroldo Ramanzini Junior, et al.
Published: (2023-11-01)

China rising - strategies and tactics of China's growing presence in the world: a special issue of RBPI
by: Henrique Altemani de Oliveira, et al.
Published: (2014-01-01)

Economia internacional e desenvolvimento econômico: a RBPI na vanguarda do pensamento brasileiro
by: Paulo Roberto de Almeida
Published: (1998-01-01)

Total Marrow and Lymphoid Irradiation: A New Technology Assisting in Myeloablating Before Hematopoietic Stem Cell Transplantation
by: SHEN Jing, et al.
Published: (2023-07-01)

Global climate governance and transition to a low-carbon economy: a special issue of RBPI[subtitle]
by: Eduardo Viola, et al.
Published: (2012-01-01)

Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation
by: Maite Alvarez, et al.
Published: (2021-01-01)

Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation
by: Alberto Olaya Vargas, et al.
Published: (2013-01-01)

O ano que ainda não terminou nas relações internacionais: 1962 nas páginas da RBPI
by: Antônio Carlos Lessa, et al.
Published: (2012-12-01)

O ano que ainda não terminou nas relações internacionais: 1962 nas páginas da RBPI
by: Antônio Carlos Lessa, et al.
Published: (2012-12-01)

Allogeneic hematopoietic stem cell transplantation with the modified myeloablative conditioning regimen for children with chronic active Epstein–Barr virus infection
by: Yanhui Luo, et al.
Published: (2022-12-01)

Comment on: Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation
by: Morris Kletzel
Published: (2013-01-01)

BPI Process and its epistemological specificities
by: Flávio Campos, et al.
Published: (2015-06-01)

Tissue Damage Caused by Myeloablative, but Not Non-Myeloablative, Conditioning before Allogeneic Stem Cell Transplantation Results in Dermal Macrophage Recruitment without Active T-Cell Interaction
by: Peter van Balen, et al.
Published: (2018-02-01)

The effect of myeloablative radiation on urinary bladder mast cells
by: Jessica Smith, et al.
Published: (2024-03-01)

Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Cohort Study
by: Rafiye Çiftçiler, et al.
Published: (2019-05-01)

Business process improvement (BPI) in an enterprise company /
by: Norasikin Salim, 1978- author, et al.
Published: (2014)

Business process improvement (BPI) in an enterprise company
by: Salim, Norasikin
Published: (2014)

They Were at the Head of BSPI – BPI – BSPA – BNTU
by: G. A. Vershina, et al.
Published: (2020-11-01)

The application of ECL reaction of Ru(bpy)32+
by: Pongsathorn Amornpitoksuk
Published: (2003-01-01)

Serum BPI as a novel biomarker in asthma
by: Chen Xingyuan, et al.
Published: (2020-06-01)

(GT)n Repeat Polymorphism in Heme Oxygenase-1 (HO-1) Correlates with Clinical Outcome after Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation.
by: Tania Køllgaard, et al.
Published: (2016-01-01)

Comparison of outcomes in hematological malignancies treated with haploidentical or HLA-identical sibling hematopoietic stem cell transplantation following myeloablative conditioning: A meta-analysis.
by: Dangui Chen, et al.
Published: (2018-01-01)

Classical transplantation tolerance in the adult: the interaction between myeloablation and immunosuppression.
by: Leong, L, et al.
Published: (1992)

Myeloablative conditioning with total body irradiation for AML: Balancing survival and pulmonary toxicity
by: Sarah J. Stephens, MD, et al.
Published: (2016-10-01)

THE CRYSTAL STRUCTURE OF DIBROMOBIPYRIDINELEAD(II), [PbBr2(bpy)]
by: Casas, José S., et al.
Published: (2001-07-01)

Residual Disease Detection by Flow Cytometry Predicts Risk of Relapse and Overall Survival in Patients with Acute Myeloid Leukemia Following Reduced Intensity- and Myeloablative-Allogeneic Hematopoietic Cell Transplantation
by: Bradbury, C, et al.
Published: (2012)